🔗 Permalink

Inventor profile of:

Stephen Withers

City:

Vancouver

Country:

Canada

Published Applications:

Last publication date:

2020-01-23

Top Assignees for applications by Stephen Withers

The entities that hold a legal rights for patent applications filed by inventor Withers Stephen:

The University of British Columbia 10 Vancouver, Canada
Seneb BioSciences, Inc. 2 North Wales, PA United States
LA JOLLA PHARMACEUTICAL COMPANY 1 San Diego, CA United States
The University of British Columbia University- Industry Liaison Office 1 Vancouver, Canada
THE UNIVERSITY OF BRITISH COLUMBIA UNIVERSITY-INDU 1 Vancouver, BC Canada
The Hospital for Sick Children 1 Toronto, Canada
The University of British Columbia 1 , Canada
The University of British Columbia 1 Vancouver, BC Canada

Recent patent applications by Withers Stephen

Stephen Withers from Vancouver, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-01-23

US20200024628A1

Chemistry; metallurgy

MUTANT ENDOGLYCOCERAMIDASES WITH ENHANCED SYNTHETIC ACTIVITY

#2 | 2018-10-04

US20180282293A1

Chemistry; metallurgy

Neuraminidase Inhibitor Compounds, Compositions and Methods for the Use Thereof in Anti-Viral Treatments

#3 | 2018-03-01

US20180057474A1

Chemistry; metallurgy

2,3-Fluorinated Glycosides as Neuraminidase Inhibitors and Their Use as Anti-Virals

#4 | 2017-06-15

US20170165223A1

Human necessities

3′ equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals

#5 | 2017-01-26

US20170022177A1

Chemistry; metallurgy

Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments

#6 | 2016-03-10

US20160068501A1

Chemistry; metallurgy

2,3-Fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals

#7 | 2016-02-04

US20160032342A1

Chemistry; metallurgy

Mutant endoglycoceramidases with enhanced synthetic activity

#8 | 2015-08-06

US20150216838A1

Human necessities

Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments

#9 | 2015-06-11

US20150158899A1

Chemistry; metallurgy

2,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals

#10 | 2014-11-27

US20140350095A1

Chemistry; metallurgy

3′ Equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals

#11 | 2014-05-29

US20140147891A1

Chemistry; metallurgy

Mutant endoglycoceramidases with enhanced synthetic activity

#12 | 2012-07-19

US20120184606A1

Chemistry; metallurgy

Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments

#13 | 2012-07-12

US20120178802A1

Chemistry; metallurgy

2,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals

#14 | 2011-08-04

US20110189107A1

Chemistry; metallurgy

Alpha-amylase inhibitors: the montbretins and uses thereof

#15 | 2009-07-02

US20090170155A1

Chemistry; metallurgy

Mutant Endoglycoceramidases With Enhanced Synthetic Activity

#16 | 2007-03-22

US20070066543A1

Human necessities

Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity

InventorID:

778878 ⎘